AHA Statement on the Nomination of Dr. Stephen Hahn as FDA Commissioner

Rick Pollack
President and CEO
American Hospital Association

November 1, 2019

The AHA welcomes the nomination of Dr. Stephen Hahn, a renowned oncologist and physician leader, to be the next commissioner of the Food and Drug Administration. As the chief medical executive at The University of Texas MD Anderson Cancer Center, Dr. Hahn leads the medical practice at one of the world’s top hospitals devoted to cancer care, research, education and prevention. We believe that Dr. Hahn’s more than 20 years of experience on the front lines of delivering patient care, overseeing clinical research and operations, and quality and safety initiatives makes him a uniquely qualified nominee to lead the FDA.

The AHA looks forward to working with Dr. Hahn to achieve our mission of advancing the health of the patients and communities we are privileged to serve each day.



Colin Milligan, (202) 638-5491; cmilligan@aha.org

Marie Johnson, (202) 626-2351; mjohnson@aha.org

Related Resources

The Federation of American Hospitals and the American Hospital Association, urge Congress to oppose S. 2860 and any other legislation that would repeal current…
AHA letter expressing support for the Maternal Health Quality Improvement Act (H.R.
AHA letter expressing support for the Helping Medicaid Offer Maternity Services Act (H.R.
EtO Quality Advisory Overview: The AHA and AHRMM have released a Quality Advisory on ethylene oxide sterilization of medical de
The Centers for Medicare & Medicaid Services (CMS) Nov.
Special Bulletin
The Administration today released a final rule requiring hospitals to disclose payer-specific negotiated rates, along with a proposed rule that would impose…